Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase
Here the authors combine next generation sequencing on plasma from participants of the ADVANCE clinical trial with virological and follow-up data to investigate the impact of pre-treatment drug resistance (PDR) to non-nucleoside reverse transcriptase inhibitors (NNRTIs) on the efficacy of second-gen...
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1698782bd5904ceaa2191d4ec77b5aff |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:1698782bd5904ceaa2191d4ec77b5aff |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:1698782bd5904ceaa2191d4ec77b5aff2021-12-02T15:39:13ZReduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase10.1038/s41467-020-19801-x2041-1723https://doaj.org/article/1698782bd5904ceaa2191d4ec77b5aff2020-12-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-19801-xhttps://doaj.org/toc/2041-1723Here the authors combine next generation sequencing on plasma from participants of the ADVANCE clinical trial with virological and follow-up data to investigate the impact of pre-treatment drug resistance (PDR) to non-nucleoside reverse transcriptase inhibitors (NNRTIs) on the efficacy of second-generation integrase inhibitors and find an association between NNRTI resistance prior to treatment and long-term treatment.Mark J. SiednerMichelle A. MoorhouseBryony SimmonsTulio de OliveiraRichard LessellsJennifer GiandhariStephen A. KempBenjamin ChimukangaraGodspower AkpomiemieCelicia M. SerenataWillem D. F. VenterAndrew HillRavindra K. GuptaNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-10 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Mark J. Siedner Michelle A. Moorhouse Bryony Simmons Tulio de Oliveira Richard Lessells Jennifer Giandhari Stephen A. Kemp Benjamin Chimukangara Godspower Akpomiemie Celicia M. Serenata Willem D. F. Venter Andrew Hill Ravindra K. Gupta Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase |
description |
Here the authors combine next generation sequencing on plasma from participants of the ADVANCE clinical trial with virological and follow-up data to investigate the impact of pre-treatment drug resistance (PDR) to non-nucleoside reverse transcriptase inhibitors (NNRTIs) on the efficacy of second-generation integrase inhibitors and find an association between NNRTI resistance prior to treatment and long-term treatment. |
format |
article |
author |
Mark J. Siedner Michelle A. Moorhouse Bryony Simmons Tulio de Oliveira Richard Lessells Jennifer Giandhari Stephen A. Kemp Benjamin Chimukangara Godspower Akpomiemie Celicia M. Serenata Willem D. F. Venter Andrew Hill Ravindra K. Gupta |
author_facet |
Mark J. Siedner Michelle A. Moorhouse Bryony Simmons Tulio de Oliveira Richard Lessells Jennifer Giandhari Stephen A. Kemp Benjamin Chimukangara Godspower Akpomiemie Celicia M. Serenata Willem D. F. Venter Andrew Hill Ravindra K. Gupta |
author_sort |
Mark J. Siedner |
title |
Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase |
title_short |
Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase |
title_full |
Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase |
title_fullStr |
Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase |
title_full_unstemmed |
Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase |
title_sort |
reduced efficacy of hiv-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase |
publisher |
Nature Portfolio |
publishDate |
2020 |
url |
https://doaj.org/article/1698782bd5904ceaa2191d4ec77b5aff |
work_keys_str_mv |
AT markjsiedner reducedefficacyofhiv1integraseinhibitorsinpatientswithdrugresistancemutationsinreversetranscriptase AT michelleamoorhouse reducedefficacyofhiv1integraseinhibitorsinpatientswithdrugresistancemutationsinreversetranscriptase AT bryonysimmons reducedefficacyofhiv1integraseinhibitorsinpatientswithdrugresistancemutationsinreversetranscriptase AT tuliodeoliveira reducedefficacyofhiv1integraseinhibitorsinpatientswithdrugresistancemutationsinreversetranscriptase AT richardlessells reducedefficacyofhiv1integraseinhibitorsinpatientswithdrugresistancemutationsinreversetranscriptase AT jennifergiandhari reducedefficacyofhiv1integraseinhibitorsinpatientswithdrugresistancemutationsinreversetranscriptase AT stephenakemp reducedefficacyofhiv1integraseinhibitorsinpatientswithdrugresistancemutationsinreversetranscriptase AT benjaminchimukangara reducedefficacyofhiv1integraseinhibitorsinpatientswithdrugresistancemutationsinreversetranscriptase AT godspowerakpomiemie reducedefficacyofhiv1integraseinhibitorsinpatientswithdrugresistancemutationsinreversetranscriptase AT celiciamserenata reducedefficacyofhiv1integraseinhibitorsinpatientswithdrugresistancemutationsinreversetranscriptase AT willemdfventer reducedefficacyofhiv1integraseinhibitorsinpatientswithdrugresistancemutationsinreversetranscriptase AT andrewhill reducedefficacyofhiv1integraseinhibitorsinpatientswithdrugresistancemutationsinreversetranscriptase AT ravindrakgupta reducedefficacyofhiv1integraseinhibitorsinpatientswithdrugresistancemutationsinreversetranscriptase |
_version_ |
1718385915526643712 |